Simulations Plus (NASDAQ:SLP) Trading Down 11.5% - What's Next?

Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report)'s stock price was down 11.5% during trading on Monday . The company traded as low as $29.43 and last traded at $28.19. Approximately 39,996 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 218,848 shares. The stock had previously closed at $31.85.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on SLP. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a research note on Tuesday. Wall Street Zen raised Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Finally, KeyCorp upped their price target on shares of Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $50.00.

Simulations Plus Trading Down 1.7%

The firm has a 50 day moving average price of $30.50 and a 200 day moving average price of $30.39. The stock has a market capitalization of $554.06 million, a PE ratio of 68.88 and a beta of 1.10.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.06. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The business had revenue of $22.43 million during the quarter, compared to analyst estimates of $21.93 million. During the same quarter in the previous year, the company posted $0.20 earnings per share. Simulations Plus's revenue for the quarter was up 22.5% on a year-over-year basis. On average, equities research analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Insider Activity at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total transaction of $670,200.00. Following the sale, the director now directly owns 3,344,157 shares in the company, valued at $112,062,701.07. This trade represents a 0.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 19.40% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Simulations Plus

Institutional investors and hedge funds have recently bought and sold shares of the business. Janus Henderson Group PLC boosted its stake in shares of Simulations Plus by 7,753.3% in the fourth quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company's stock worth $15,141,000 after acquiring an additional 535,986 shares during the period. Conestoga Capital Advisors LLC lifted its holdings in Simulations Plus by 17.2% in the 1st quarter. Conestoga Capital Advisors LLC now owns 2,609,388 shares of the technology company's stock worth $63,982,000 after purchasing an additional 383,126 shares in the last quarter. Royce & Associates LP boosted its stake in Simulations Plus by 56.6% in the 4th quarter. Royce & Associates LP now owns 371,797 shares of the technology company's stock worth $10,369,000 after purchasing an additional 134,381 shares during the period. Nicholas Company Inc. purchased a new stake in Simulations Plus during the 4th quarter valued at approximately $3,418,000. Finally, Kennedy Capital Management LLC grew its holdings in Simulations Plus by 59.4% during the 4th quarter. Kennedy Capital Management LLC now owns 289,286 shares of the technology company's stock valued at $8,068,000 after buying an additional 107,766 shares in the last quarter. 78.08% of the stock is owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.